A randomized, open label, multicentric, phase II clinical trial to assess the immunogenicity and safety of Measles, Mumps and Rubella (MMR) vaccine (Live) (Freeze-dried) of M/s Cadila Healthcare Ltd. in healthy pediatric subjects aged 15-18 months

Trial Profile

A randomized, open label, multicentric, phase II clinical trial to assess the immunogenicity and safety of Measles, Mumps and Rubella (MMR) vaccine (Live) (Freeze-dried) of M/s Cadila Healthcare Ltd. in healthy pediatric subjects aged 15-18 months

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Sep 2016

At a glance

  • Drugs Measles mumps and rubella virus vaccine (Primary)
  • Indications Measles; Mumps; Rubella
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Cadila Healthcare
  • Most Recent Events

    • 11 Nov 2014 Status changed from recruiting to completed.
    • 19 Feb 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top